Anand Mehra

Insider Reports History

Location
Menlo Park, CA
Signature
/s/ Peter Silverman as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Anand Mehra:

Company Role Class Num Shares Value Price $ Report Date Ownership
Aclaris Therapeutics, Inc. Director Common Stock 714,823 $1,093,679 $1.53 06 Jun 2025 Direct
Merus N.V. Director Share Option (right to buy) 0 $119,571 $13.52 12 Dec 2025 Direct
Aclaris Therapeutics, Inc. Director Restricted Stock Units 0 $4,937 $1.03 06 Jun 2025 Direct
Aclaris Therapeutics, Inc. Director Stock Option (Right to Buy) 42,350 05 Jun 2025 Direct

Insider Reports Filed by Anand Mehra

Symbol Company Period Transactions Value $ Form Type Role Filing Time
MRUS Merus N.V. 12 Dec 2025 10 $0 4 Director 12 Dec 2025, 19:05
ACRS Aclaris Therapeutics, Inc. 05 Jun 2025 4 $0 4 Director 09 Jun 2025, 16:20
MRUS Merus N.V. 22 May 2025 1 $0 4 Director 27 May 2025, 08:00
ACRS Aclaris Therapeutics, Inc. 19 Nov 2024 1 +$1,499,998 4 Director 20 Nov 2024, 16:20
ACRS Aclaris Therapeutics, Inc. 06 Jun 2024 2 $0 4 Director 10 Jun 2024, 16:15
ACRS Aclaris Therapeutics, Inc. 01 Jun 2024 2 $0 4 Director 04 Jun 2024, 16:30
MRUS Merus N.V. 07 May 2024 1 $0 4 Director 09 May 2024, 16:30
MRUS Merus N.V. 08 Jun 2023 1 $0 4 Director 12 Jun 2023, 16:14
ACRS Aclaris Therapeutics, Inc. 01 Jun 2023 4 $0 4 Director 05 Jun 2023, 16:45
ACRS Aclaris Therapeutics, Inc. 02 Jun 2022 4 $0 4 Director 06 Jun 2022, 17:21
MRUS Merus N.V. 31 May 2022 1 $0 4 Director 02 Jun 2022, 16:06
ACRS Aclaris Therapeutics, Inc. 03 Jun 2021 2 $0 4 Director 04 Jun 2021, 20:00
MRUS Merus N.V. 28 May 2021 1 $0 4 Director 02 Jun 2021, 16:10